When DAS28-CRP scores were assessed using EULAR response criteria, 90% and 78% of patients were categorized as showing good or moderate response in the early and established RA groups, respectively, with no significant difference apparent between groups. The gene discussed is CRP; the disease is rheumatoid arthritis.